海特生物：授权管理层启动发行H股并在香港联交所上市筹备工作

Core Viewpoint - Hite Bio (300683) plans to issue shares overseas (H-shares) and list on the Hong Kong Stock Exchange, with the board authorizing management to initiate preparatory work for the H-share listing [1] Group 1 - The company is in discussions with relevant intermediaries regarding the specific progress of the H-share listing [1] - Details of the H-share listing have not yet been determined [1]